Process: submission:12/21/2021 acceptance:05/08/2022 study of and c-kit gene mutations in patients with v617f

HIGHLIGHTS

  • who: CALRecticulin (CALR) mutation- myeloproliferative and collaborators from the (UNIVERSITY) have published the Article: Process: Submission:12/21/2021 Acceptance:05/08/2022 Study of and c-kit Gene Mutations in Patients with V617F, in the Journal: (JOURNAL)
  • what: The aim of this study to determine the prevalence of and c-kit gene mutations in V617F patients.
  • how: The results showed that 66% of cases were because they lacked mutations in and genes. The result showed that the vaccine could activate the immune respond in PV patients but it could not activate in . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?